GeneDx Holdings Corp. (WGS) Financial Analysis & Valuation | Quarter Chart
GeneDx Holdings Corp. (WGS)
WGSPrice: $65.96
Fair Value: 🔒
🔒score
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajector... more
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming ... more
Description
Shares
| Market Cap | $1.93B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Healthcare Information Services |
| Country | US | CEO | Katherine A. Stueland |
| IPO Date | 2020-11-04 | CAGR | 0.09% |
| Employees | 1,000 | Website | www.genedx.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
WGS chart loading...
Fundamentals
Technicals
| Enterprise Value | $1.04B | P/E Ratio | -90.36 |
| Forward P/E | 32.06 | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | — |
| P/CF Ratio | — | P/FCF Ratio | — |
| EPS | $-0.73 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 50.5% | Gross Margin | 0.7% |
| Operating Margin | 0.02% | Profit Margin | 0.01% |
| ROE | 0.01% | ROA | — |
| ROCE | 0.02% | Current Ratio | 2.71 |
| Quick Ratio | 2.59 | Cash Ratio | 1.1 |
| Debt/Equity | 0.21 | Interest Coverage | 3.67 |
| Altman Z Score | 3.07 | Piotroski Score | 7 |